Press release
Global Peripheral Vascular Devices Market to Reach USD 15.54 Billion by 2032, Driven by Rising PAD Burden and Surge in Minimally Invasive Interventions | DelveInsight
The global peripheral vascular devices market is poised for steady and sustained expansion, fueled by the increasing prevalence of vascular diseases, rapid technological innovation, and the accelerating shift toward minimally invasive procedures.According to DelveInsight's latest analysis, the market size is expected to grow from USD 9,853.30 million in 2024 to USD 15,544.32 million by 2032, registering a compound annual growth rate (CAGR) of 5.92% during the forecast period from 2025 to 2032.
Peripheral vascular devices, which include angioplasty balloons, stents, atherectomy systems, thrombectomy devices, and embolic protection systems, play a critical role in diagnosing and treating disorders of blood vessels outside the heart and brain. These devices are increasingly becoming indispensable in modern healthcare systems due to their ability to restore blood flow, reduce complications, and improve patient outcomes-particularly in conditions such as Peripheral Artery Disease (PAD).
Rising Disease Burden and Lifestyle Risk Factors Fuel Market Growth
One of the primary drivers propelling the growth of the peripheral vascular devices market is the increasing global burden of Peripheral Artery Disease (PAD) and other vascular disorders. Factors such as diabetes, obesity, hypertension, smoking habits, and sedentary lifestyles are contributing significantly to the rising incidence of vascular complications worldwide.
Recent epidemiological insights indicate that hundreds of millions of individuals globally are living with cardiovascular and circulatory diseases, creating a substantial demand for effective vascular interventions. PAD alone affects millions of adults globally, with prevalence increasing sharply among individuals aged 40 years and above. The condition often leads to arterial narrowing due to plaque buildup, necessitating the use of devices such as angioplasty balloons and stents to restore adequate blood flow.
As awareness around early diagnosis and treatment continues to improve, healthcare providers are increasingly adopting advanced peripheral vascular devices to manage disease progression and prevent severe complications such as limb ischemia and amputation.
Unlock in-depth market insights and forecasts here: https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Minimally Invasive Procedures Transforming Vascular Care
A major trend reshaping the peripheral vascular devices market is the growing preference for minimally invasive procedures. Compared to traditional open surgeries, minimally invasive interventions offer multiple clinical and economic advantages, including:
• Reduced hospital stays
• Faster recovery times
• Lower risk of complications
• Improved patient satisfaction
Devices such as drug-eluting stents, drug-coated balloons, and endovascular aneurysm repair (EVAR) systems are increasingly being used in catheter-based procedures, allowing physicians to treat complex vascular conditions with greater precision and safety.
This paradigm shift is not only improving patient outcomes but also reducing the overall burden on healthcare systems, making minimally invasive technologies a cornerstone of modern vascular treatment.
Technological Advancements Accelerating Innovation
The peripheral vascular devices market is witnessing rapid technological advancements, enabling the development of next-generation devices that offer enhanced performance and safety.
Key innovations include:
• Drug-eluting technologies that reduce restenosis rates
• Bioresorbable scaffolds that dissolve after restoring vessel function
• Advanced imaging-guided delivery systems for precise placement
• Intravascular lithotripsy (IVL) for treating calcified lesions
These advancements are significantly improving procedural success rates and long-term outcomes. For instance, recent product launches such as the CLEANER VacTM Thrombectomy System highlight the industry's focus on addressing unmet clinical needs through innovation.
Explore the latest trends and technological breakthroughs: https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Peripheral Vascular Devices Competitive Landscape: Dominance of Global MedTech Leaders
The global peripheral vascular devices market is moderately consolidated, with several multinational corporations leading innovation and market expansion.
Key Peripheral Vascular Devices Companies include:
• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• B. Braun SE
• W. L. Gore & Associates, Inc.
• Edwards Lifesciences Corporation
These companies leverage extensive product portfolios, strong distribution networks, and significant investments in R&D to maintain their competitive edge. Strategic initiatives such as mergers, acquisitions, and partnerships are further strengthening their market positions.
For example, recent acquisitions and regulatory approvals have expanded product offerings and accelerated innovation, enabling companies to address increasingly complex vascular conditions.
Angioplasty Stents Segment Leads the Market
Among product types, the angioplasty stents segment is expected to account for the largest share of the peripheral vascular devices market in 2024. Within this category, drug-eluting stents (DES) are gaining significant traction due to their superior clinical outcomes.
DES release therapeutic agents directly at the site of arterial blockage, effectively reducing the risk of restenosis and improving long-term vessel patency. These devices are particularly beneficial for patients with complex lesions and high-risk profiles.
The growing adoption of DES is supported by:
• Strong clinical evidence
• Technological advancements
• Favorable reimbursement policies
Additionally, innovations such as bioresorbable stents are expected to further revolutionize vascular care by offering temporary support while restoring natural vessel function.
Gain detailed segmentation insights and market forecasts: https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Hospitals Remain the Dominant End-Users
Hospitals continue to dominate the peripheral vascular devices market, accounting for a significant share due to their:
• Advanced infrastructure
• Availability of skilled specialists
• High patient inflow for complex procedures
These facilities are often early adopters of innovative technologies and play a crucial role in driving demand for advanced vascular devices. The presence of specialized catheterization labs and vascular surgery units further enhances their ability to perform complex interventions.
Peripheral Vascular Devices Regional Insights: North America Leads, Asia-Pacific Emerges
North America Peripheral Vascular Devices Market: Market Leader
North America is expected to dominate the global peripheral vascular devices market, driven by:
• High prevalence of PAD and related conditions
• Advanced healthcare infrastructure
• Strong reimbursement frameworks
• Presence of leading industry players
The region also benefits from continuous innovation and rapid adoption of new technologies, ensuring sustained market leadership.
Europe Peripheral Vascular Devices Market: Strong Adoption of Advanced Technologies
Europe represents a mature and competitive market, characterized by:
• High adoption of minimally invasive procedures
• Growing use of advanced devices such as drug-coated balloons and IVL systems
• Strong healthcare systems in countries like Germany, France, and the UK
Asia-Pacific Peripheral Vascular Devices Market: Fastest Growing Market
The Asia-Pacific region is emerging as the fastest-growing market, driven by:
• Large patient population
• Rising prevalence of chronic diseases
• Increasing healthcare investments
• Growing awareness and diagnosis rates
Countries such as China and India are expected to play a pivotal role in regional growth, supported by expanding healthcare infrastructure and medical tourism.
Discover regional opportunities and growth hotspots: https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Challenges Hindering Peripheral Vascular Devices Market Growth
Despite strong growth prospects, the peripheral vascular devices market faces several challenges:
• High cost of devices and procedures
• Complex regulatory approval processes
• Reimbursement limitations
• Competition from alternative treatments
• Lack of skilled professionals in certain regions
Addressing these challenges will be critical for ensuring broader adoption and sustained market growth.
Peripheral Vascular Devices Emerging Trends: AI, Innovation, and Investment
The integration of artificial intelligence (AI) is expected to transform the peripheral vascular devices market by enhancing:
• Diagnostic accuracy
• Treatment planning
• Device design and manufacturing
• Market intelligence and strategy
Additionally, increasing startup funding and investment in innovative technologies are driving the development of next-generation solutions. Emerging players are focusing on specialized devices and novel approaches to address unmet clinical needs.
Recent Industry Developments Highlight Innovation Momentum
Recent developments underscore the dynamic nature of the peripheral vascular devices market:
• New product launches in thrombectomy and embolic protection
• Regulatory approvals for advanced stent systems
• Strategic acquisitions strengthening market positions
• Partnerships aimed at expanding distribution and innovation
These developments reflect the industry's commitment to advancing vascular care and improving patient outcomes.
Access the complete report and strategic insights: https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Conclusion: A Promising Future for Peripheral Vascular Devices
In conclusion, the global peripheral vascular devices market is set for robust and sustained growth, driven by a combination of rising disease burden, technological innovation, and increasing adoption of minimally invasive procedures.
As healthcare systems continue to evolve and prioritize patient-centric care, peripheral vascular devices will play an increasingly vital role in managing vascular diseases and improving quality of life for millions of patients worldwide.
With strong market fundamentals, continuous innovation, and expanding global demand, the peripheral vascular devices market presents significant opportunities for stakeholders across the healthcare ecosystem.
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peripheral Vascular Devices Market to Reach USD 15.54 Billion by 2032, Driven by Rising PAD Burden and Surge in Minimally Invasive Interventions | DelveInsight here
News-ID: 4500295 • Views: …
More Releases from DelveInsight Business Research
Injectable Drug Delivery Devices Market Set to Surpass USD 1 Trillion by 2032 Am …
The global injectable drug delivery devices market is entering a transformative growth phase, driven by a convergence of rising chronic disease prevalence, rapid expansion of biologics and biosimilars, and continuous technological innovation.
According to the latest analysis, the market is projected to grow from USD 570.77 billion in 2024 to USD 1,056.10 billion by 2032, registering a compound annual growth rate (CAGR) of 8.10% during the forecast period from 2025…
Interventional Cardiology Devices Market Set to Surpass USD 34.8 Billion by 2032 …
The global interventional cardiology devices market is entering a transformative growth phase, fueled by the increasing prevalence of cardiovascular diseases (CVDs), expanding adoption of minimally invasive procedures, and continuous innovation in device technologies.
According to the latest analysis, the Interventional Cardiology Devices market is projected to grow from USD 20,192.60 million in 2024 to USD 34,866.30 million by 2032, registering a compound annual growth rate (CAGR) of 7.09% during 2025-2032.
This…
Liver Cancer Pipeline Grows as 70+ Pharma Companies Advance Novel Liver Cancer T …
DelveInsight's "Liver Cancer - Pipeline Insight, 2026" report provides comprehensive insights about 70+ companies developing several pipeline drugs in the Liver Cancer pipeline landscape. It covers the Liver Cancer pipeline drug profiles, including clinical and nonclinical stage products, along with therapeutics assessment by product type, stage, route of administration, and molecule type, and further highlights inactive pipeline products in this space.
Explore the latest breakthroughs in the Liver Cancer treatment landscape.…
Drug-Resistant Epilepsy Market is expected to grow at a decent CAGR by 2036 | De …
DelveInsight anticipates notable growth in the drug-resistant epilepsy market between 2025 and 2034, fueled by rising disease prevalence, better diagnostic capabilities, advancements in treatment options, an aging population, heightened awareness, and favorable regulatory support across the 7MM. Furthermore, the introduction of upcoming therapies is expected to further accelerate market expansion.
A recently released Drug-Resistant Epilepsy Market Insights report offers an in-depth overview of current treatment approaches, emerging therapies, individual drug market…
More Releases for Peripheral
Key Trends Reshaping the Peripheral Arterial Disease Market: Innovative Shockwav …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Peripheral Arterial Disease Market Size Growth Forecast: What to Expect by 2025?
The overall valuation of the peripheral arterial disease sector has seen substantial expansion lately, projected to climb from $4.36 billion recorded in 2024 to reach $4.74 billion by 2025, reflecting an 8.7% compound annual growth rate over…
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive…
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of…
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorder…
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.
Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533
The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a…
